Patent · US Active

Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856

US9579352B2 · kind B2 · utility

4Cited by

1References

3Claims

0Family size

Assignee

SAMI LABS LIMITED · IN

Inventors

Muhammed Majeed · Plainsboro, US
Kalyanam Nagabhushanam · Plainsboro, US
Natarajan Sankaran · Kanchinakote, IN
Priti Vaidyanathan · Bengaluru, IN
Sivakumar Arumugam · Kanchinakote, IN
Suresh Karri · Bengaluru, IN

Key dates

Filing date	Nov 10, 2014
Grant date	Feb 28, 2017
Priority date	—
Expiry date	Nov 10, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/115
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.